Cholesterol homeostasis in cardiovascular disease and recent advances in measuring cholesterol signatures

Area of Science:

• Biochemistry
• Metabolic Medicine
• Cardiovascular Science

Background:

• Cholesterol is biochemically vital, but its dysregulation causes cellular issues and endocrine disorders like cardiovascular disease (CVD).
• The link between blood cholesterol levels and CVD risk, especially in older adults, remains controversial, impacting treatment strategies.
• Aging exacerbates CVD prevalence, yet the specific mechanisms and the role of metabolic changes in atherogenesis are not fully elucidated.

Purpose of the Study:

• To highlight the need for quantifying circulating biomarkers of cholesterol homeostasis.
• To establish reference values for cholesterol absorption and synthesis to better define CVD risk factors.
• To explore mass spectrometry-based cholesterol profiling as a superior method for assessing cholesterol's active component and metabolic alterations.

Main Methods:

• Utilizing mass spectrometry for precise quantification of free cholesterol, its precursors, metabolites, and dietary sterols.
• Analyzing alterations in metabolic pathways governing cholesterol homeostasis.
• Comparing mass spectrometry's accuracy with traditional, often derived, lipid profiles.

Main Results:

• Mass spectrometry provides accurate measurements of free cholesterol, a key biologically active form.
• This method can detect subtle changes in cholesterol metabolism and identify pathway alterations.
• It offers a more reliable approach than traditional lipid profiles for understanding cholesterol's role.

Conclusions:

• Accurate cholesterol quantification via mass spectrometry is crucial for identifying reliable CVD risk biomarkers.
• Understanding cholesterol homeostasis mechanisms can reveal predictive markers for atherosclerosis and conventional CVD risks.
• Further research into cholesterol metabolism is warranted to refine CVD risk assessment and treatment, particularly in aging populations.